New SGLT2 inhibitor ertugliflozin: safe and effective in the management of type 2 diabetes
Type 2 diabetes mellitus (T2DM) is closely associated with the risk of developing cardiovascular complications.A new Electric Tools approach to treatment of T2DM, based on the inhibition of the sodium-glucose cotransporter type 2 (SGLT2) ensures reliable insulin-independent glycemic control with quick overcome of glucotoxicity, reduction of insulin